Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa dose-exploration study of EM mycobacterial skin test antigen in adults aged 18-65 years
CTR20240773Phase 2Active
- Sponsor
- Ambience Healthcare
- Start
- Apr 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of mycobacterium tuberculosis antigen in Tuberculosis (TB), latent tuberculosis infection (LTBI), sponsored by Ambience Healthcare. Started Apr 2024; status: active.
02
Drugs
mycobacterium tuberculosis antigen
03
Conditions
Tuberculosis (TB)latent tuberculosis infection (LTBI)
Beyond the preview
Go deeper on CTR20240773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20240773.